Sector-focused investor MedCare Investment Funds has hired John Doulis as the chief information officer for its funds and portfolio companies.
“MedCare is thrilled to add Dr Doulis to our team. He brings a breadth of knowledge about information sciences and technology and its role in healthcare and biomedical science. His knowledge, experience and insight will help shape our investment decisions and sharpen the value of our portfolio companies,” said Thomas Lyles, Sr, president of MedCare. “John is a luminary in health care IT and understands the emerging power of information management, data analysis and information sharing to transform medicine.”
Doulis is a physician executive with more than 20 years spent in designing, managing and perfecting information systems that support health enterprises. As assistant vice chancellor for health affairs at Vanderbilt University, he was the COO for an $80m department with 450 employees.
“Making health care delivery more effective, more efficient, of higher quality and offering better outcomes is the goal. In so many ways, information technologies will play a major role in that transformation,” said Doulis. “From reducing errors to ensuring that the highest standards of evidence-based medicine are applied to every patient, from delivering the right information at the right time to remembering a patient’s genomic and proteomic profile, information is the enabling technology that will transform healthcare. Working with a team of extraordinary talents here at MedCare will give me a chance to help direct and deliver those transformative information technologies to health care providers across the world.”
As a practicing physician Dr. Doulis focused on men’s health and on the application of information technologies.
MedCare manages approximately $1bn in assets, the substantial majority of which are related to the medical and healthcare services industry. Currently it has a portfolio of fifteen healthcare companies representing most sectors of the healthcare industry including services, information technologies, medical devices, pharma, and biotechnology.
Copyright © 2012 AltAssets